SEER, INC. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- SEER, INC. payments for repurchase of common stock for the quarter ending 2024-12-31 was $0.00.
- SEER, INC. payments for repurchase of common stock for the quarter ending 2024-09-30 was -$3.75M, a 28923.08% decline year-over-year.
- SEER, INC. payments for repurchase of common stock for the quarter ending 2023-12-31 was $0.00.
- SEER, INC. payments for repurchase of common stock for the quarter ending 2023-09-30 was $13.00K.
- SEER, INC. payments for repurchase of common stock for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- SEER, INC. payments for repurchase of common stock for fiscal 2023 was $13.00K, a 35.00% decline from fiscal 2022.
- SEER, INC. payments for repurchase of common stock for fiscal 2022 was $20.00K, a 42.86% decline from fiscal 2021.
- SEER, INC. payments for repurchase of common stock for fiscal 2021 was $35.00K, a 169.23% increase from fiscal 2020.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $0.00 10-K · filed 2025-03-03 |
| 2024-09-30 | -$3.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $13.00K 10-K · filed 2025-03-03 |
| 2023-09-30 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $13.00K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $0.00 derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-09 | -$1.00K derived: sum of 4 quarters · filed 2024-03-04 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-04 | $20.00K 10-K · filed 2024-03-04 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $20.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $42.00K derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $21.00K 10-Q · filed 2023-05-09 | $54.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $35.00K 10-K · filed 2023-03-06 |
| 2021-09-30 | $22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $42.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $19.00K derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $2.00K 10-Q · filed 2022-05-06 | $15.00K derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $13.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | |
| 2020-06-30 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |